#checkpoint — Wednesday, September 16, 2026 (1 items)
| 0 | ℹ |
Antibodies against HLA-E-VL9 enhance NK cell and CD8(+) T cell cytotoxicity against tumor cells and HIV-infected CD4(+) T cells.
(doi.org)
|
Science Translational Medicine 2026-09-16 | #immunotherapy #checkpoint #antibody #cytotoxicity #hiv |